A detailed history of Global Retirement Partners, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 200 shares of EDIT stock, worth $634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 800 75.0%
Holding current value
$634
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$3.39 - $5.96 $2,034 - $3,576
-600 Reduced 75.0%
200 $0
Q2 2024

Jul 23, 2024

BUY
$4.67 - $7.28 $1,868 - $2,912
400 Added 100.0%
800 $3,000
Q4 2023

Jan 18, 2024

BUY
$6.25 - $11.11 $2,500 - $4,444
400 New
400 $4,000
Q3 2019

Nov 19, 2019

SELL
$22.49 - $26.81 $1,551 - $1,849
-69 Closed
0 $0
Q2 2019

Nov 19, 2019

BUY
$20.48 - $27.76 $1,413 - $1,915
69 New
69 $2,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $218M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.